5-(N,N-dimethyl)-Amiloride Hydrochloride: Selective NHE Inhibition for pH and Endothelial Injury Research

Executive Summary: 5-(N,N-dimethyl)-Amiloride (hydrochloride) is a crystalline small molecule that potently inhibits Na+/H+ exchanger isoforms NHE1, NHE2, and NHE3 with high selectivity (source: product_spec). It plays a critical role in experimental studies of intracellular pH regulation, ion transport, and endothelial injury (source: workflow_recommendation). APExBIO supplies the compound as SKU C3505, with validated solubility and storage parameters. DMA's protective effects against ischemia-reperfusion injury and its impact on sodium-potassium ATPase activity have been documented in peer-reviewed research (source: DOI). Its use is intended exclusively for scientific research, not for diagnostics or therapy.

Biological Rationale

The Na+/H+ exchanger (NHE) family maintains intracellular pH and cell volume homeostasis by exchanging intracellular protons (H+) for extracellular sodium ions (Na+). NHE1 is the predominant isoform in mammalian cells, especially in the cardiovascular system, and is essential for protecting cells against acid load. Aberrant NHE activation contributes to pathological states, including ischemia-reperfusion injury and endothelial dysfunction (source: DOI). In endothelial cells, NHE1-mediated pH regulation is intertwined with cytoskeletal dynamics and barrier integrity, with downstream links to inflammation and vascular permeability (source: workflow_recommendation).

Mechanism of Action of 5-(N,N-dimethyl)-Amiloride (hydrochloride)

5-(N,N-dimethyl)-Amiloride hydrochloride (DMA) functions as a competitive inhibitor of the Na+/H+ exchanger, specifically targeting NHE1 (Ki = 0.02 μM), NHE2 (Ki = 0.25 μM), and NHE3 (Ki = 14 μM), with minimal effect on other isoforms (source: product_spec). By blocking proton extrusion and sodium influx, DMA disrupts the maintenance of intracellular pH, attenuates sodium-dependent ATPase activity, and modulates cell volume. In cardiac tissue, this mechanism underpins its ability to prevent sodium overload and protect against contractile dysfunction during ischemic episodes. DMA's selectivity profile enables precise dissection of NHE-mediated pathways without off-target perturbation of unrelated exchangers (source: workflow_recommendation).

Evidence & Benchmarks

• DMA inhibits NHE1 with a Ki of 0.02 μM, enabling sub-micromolar blockade in cell-based assays (source: product_spec).
• DMA demonstrates >10-fold selectivity for NHE1/2 over NHE3 and negligible inhibition of NHE4, NHE5, and NHE7 (source: workflow_recommendation).
• In rat liver plasma membranes, DMA inhibits ouabain-sensitive ATP hydrolysis and Na+/K+-ATPase activity, indicating broader effects on ion transport (source: product_spec).
• DMA reduces alanine uptake in hepatocytes, linking NHE activity to amino acid transport (source: product_spec).
• DMA confers protection in cardiac ischemia-reperfusion injury models by reducing tissue sodium accumulation and preserving contractile function (source: DOI).

Compared to this earlier analysis (which established benchmark selectivity), this article updates on translational endpoints in endothelial injury and illustrates expanded use in non-cardiac models.

For practical workflow solutions, see this protocol-driven guide, which focuses on cell viability and cytotoxicity assays; our article extends to mechanistic and translational evidence, including recent sepsis-related findings.

To bridge the latest biomarker insights, we expand on perspectives introduced in translational research reviews by integrating quantitative links between NHE inhibition, pH regulation, and moesin-mediated endothelial injury.

Applications, Limits & Misconceptions

DMA is a gold-standard tool for dissecting NHE1-mediated intracellular pH regulation and ion homeostasis in mammalian cells. It is widely used in research on ischemia-reperfusion injury protection, cardiac contractile dysfunction, and endothelial barrier assays (source: DOI). In endothelial models, DMA enables mechanistic studies of NHE signaling pathway involvement in inflammation and permeability. However, its effects beyond NHE1/2/3 are minimal, limiting interpretability in non-NHE-dominant systems.

Common Pitfalls or Misconceptions

• DMA is not a broad-spectrum NHE inhibitor: Selectivity for NHE1/2/3 means negligible effects on NHE4-7, making it unsuitable for pan-NHE screening (source: workflow_recommendation).
• It is not appropriate for clinical or diagnostic use: DMA is for research applications only (source: product_spec).
• Long-term storage of DMA solutions is discouraged: Stock solutions in DMSO or DMF should be used promptly to maintain activity (source: product_spec).
• DMA does not directly modulate moesin or cytoskeletal proteins: Its effect is via pH and sodium regulation, which secondarily impact cytoskeletal dynamics (source: DOI).
• High concentrations may produce off-target effects: Use within validated assay ranges is essential to avoid non-specific actions (source: workflow_recommendation).

Workflow Integration & Parameters

Protocol Parameters

• Cell viability assay | 1–10 μM DMA | NHE1-dependent cell lines | Ensures sub-micromolar inhibition with minimal cytotoxicity | workflow_recommendation
• Cardiac ischemia-reperfusion model | 0.1–1 mg/kg DMA (in vivo) | Rodent models | Recapitulates sodium load protection validated in preclinical studies | DOI
• Endothelial barrier function assay | 1–5 μM DMA | Human microvascular endothelial cells | Probes NHE1 role in cytoskeletal regulation and permeability | DOI
• Solubility test | Up to 30 mg/ml in DMSO/DMF | All in vitro preparations | Ensures adequate working concentration and stability | product_spec
• Storage protocol | -20°C dry, dark | All stocks | Maintains compound integrity for short-term use | product_spec

Conclusion & Outlook

5-(N,N-dimethyl)-Amiloride hydrochloride, as offered by APExBIO, is a precisely characterized NHE1/2/3 inhibitor with robust utility in research on intracellular pH regulation, ion transport, and endothelial injury. Its quantitative selectivity, protocolized use, and documented efficacy in reducing ischemia-reperfusion injury make it a benchmark reagent for translational and mechanistic studies. Current evidence highlights its value in dissecting the Na+/H+ exchanger signaling pathway underlying vascular and cardiac injury, and ongoing research continues to clarify its role in linking pH regulation to cytoskeletal and biomarker dynamics. Investigators should adhere strictly to validated protocols and storage conditions to maximize reproducibility and data quality (source: product_spec).